REQUEST A DEMO
Total
USD $0.00
Search more companies

Balkanpharma Troyan AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Balkanpharma Troyan AD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Actavis EAD is a pharmaceutical company specializing in the development and distribution of a wide range of medical prescription and additional medications. They offer dermatological remedies, anti-neoplastic and immunomodulating products, digestive and metabolism medications, cardiovascular system products, respiratory system medications, and anti-infectious medicines for systemic application.

Headquarters
1 Krayrechna Str.
Troyan; Lovech; Postal Code: 5600

Contact Details: Purchase the Balkanpharma Troyan AD report to view the information.

Website: http://www.actavis.bg

Basic Information
Total Employees:
Purchase the Balkanpharma Troyan AD report to view the information.
Outstanding Shares:
Purchase the Balkanpharma Troyan AD report to view the information.
Registered Capital:
Purchase the Balkanpharma Troyan AD report to view the information.
Financial Auditors:
Purchase the Balkanpharma Troyan AD report to view the information.
Incorporation Date:
August 15, 1991
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
98.32%
Purchase this report to view the information.
0.02%
Purchase this report to view the information.
0.02%
Company Performance
Financial values in the chart are available after Balkanpharma Troyan AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
23.01%
Total operating revenue
20.94%
Net Profit (Loss) for the Period
30.92%
Total assets
17.96%
Total equity
5.21%
Net Profit Margin
0.39%
Return on Equity (ROE)
0.93%
Quick Ratio
-1.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?